Clinical Study
The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns
Table 2
The prevalence of HTLV1 antibodies in studied subjects according to the age distribution of women and their gestational age.
| | HTLV1 antibody | Negative | Positive | Total | P value | | No (%) | No (%) | No (%) |
| | Maternal age | | | | | | <21 years old | 68 (17.0%) | 0 (0.00%) | 68 (16.7%) | | | 21–30 years old | 248 (61.8%) | 6 (100.0%) | 254 (62.4%) | 0.783 | | >30 years old | 85 (21.2%) | 0 (.0%) | 85 (20.9%) | |
| | Total | 401 (100.0%) | 6 (100.0%) | 407 (100.0%) | |
| | Gestational age | | | | | | Before term | 23 (5.8%) | 0 (.0%) | 23 (5.8%) | | | Term | 347 (86.5%) | 6 (100.0%) | 353 (86.7%) | 0.271 | | After term | 31 (7.7%) | 0 (0%) | 31 (7.6%) | |
| | Total | 401 (100.0%) | 6 (100.0%) | 407 (100.0%) | |
|
|
